About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Our Product Categories
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Company News
Impairment Vs Presence Of Cannabis: The International Cannabis Driving Debate Continues
Around the world, the debate continues about how to quantify the presence of cannabis in an individual’s system and how…
Read more
Give and Toke: Excitement in Global Markets w/ Michael Sassano (SOMAÍ Pharmaceuticals)
Listen to the latest episode of the Give and Toke podcast, which elevates the conversation about cannabis to a higher…
Read more
Drug Science: What is the UK medical cannabis industry looking like in 2024?
We are 6 years on from legalisation of cannabis-based medical products in the UK and although many patients have now…
Read more
EU Medical Cannabis Meets Recreational Choice: A New Era in European Preference
Europe has been one of the most interesting cannabis markets to watch develop: What was a pure medical cannabis market has…
Read more
SOMAÍ Pharmaceuticals Announces Partnership with Releaf Clinic to Bring Innovative Cannabis Solutions to UK Patients
This collaboration marks the synergy of two vertically integrated fast-growing companies. SOMAÍ Pharmaceuticals is proud to announce a strategic partnership…
Read more
Innovations in Cannabis Extracts Entice New Demographics
Interesting trends emerge when we examine the largest extract markets in the global cannabis industry. These trends suggest that innovations…
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the…
Read more
SOMAÍ Pharmaceuticals Launches in Ireland, Offering the Broadest Range of Cannabis-Based Medicines to Patients
SOMAÍ Pharmaceuticals (“SOMAÍ”), a leading EU-GMP vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the…
Read more
What Does the Future Hold for UK Cannabis?
After a recent conversation with Pierre van Weperen of Grow Group PLC and Grow Pharma, his vision of the United Kingdom’s…
Read more
EU verticals create new European MCOs: Multi-Country Operators
New European MCOs: Multi-Country Operators European cannabis markets are heating up, and virtually every country is buzzing about regulatory change…
Read more
The Best Global Cannabis Markets By Country 2023-2024
The global cannabis universe continues to expand rapidly after the United States Department of Health and Human Services (HHS) report, Germany’s removal…
Read more
Global Cannabis: Michael Sassano, CEO and Founder at Somai Pharmaceuticals (AltMed Ep.117)
Watch the latest AltMed podcast, in which Michael Sassano and Andrew Dowling, AltMed’s co-founder, discuss different aspects of the global…
Read more
The battle for Australian-grown cannabis: quality vs global price wars
There is a buzz around Australia about “Made in Australia” products, including cannabis. Every country should be proud of its…
Read more
Cosma S.A. and SOMAÍ Pharmaceuticals partner to Revolutionize Poland with the most Innovative Cannabis-Based Solutions
LISBON, PORTUGAL, August 29, 2024 – Cosma S.A., a leader in cannabis-based pharmaceutical advancements, and SOMAÍ Pharmaceuticals, a fully vertically…
Read more
What is Spain’s New Medical Cannabis Regulatory Framework?
Ultimately, patients deserve access to safer alternatives to current over-prescribed pharmaceutical medicines. Spain has become the latest large European country…
Read more
2024’s Hottest Global Medical Cannabis Market Trends
A massive dose of energy has jolted the global cannabis markets. The United States Department of Health and Human Services (HHS)…
Read more
Sassano: Why future EU medical cannabis branding is essential
Michael Sassano is a CEO and Chairman of the Board for SOMAÍ Pharmaceuticals, a leading EU-GMP European pharmaceutical and biotech…
Read more
SOMAÍ Pharmaceuticals Expands Its Most Comprehensive Medicinal Cannabis Portfolio With Launch of New Mint Oral Solutions Line
SOMAÍ Pharmaceuticals (“SOMAÍ”), a fully vertically integrated Multi-Country Operator (MCO) in the global medical cannabis markets, is proud to announce…
Read more
Put Some Mint Terpenes In It
What is the first thing you do when you open a new bag of cannabis flower? You smell it! Cannabis…
Read more
Germany Leads The Global Medical Cannabis Explosion
The entire cannabis community is abuzz with German legalization. Not only is this a massive windfall for cannabis producers around the…
Read more